Drug Manufacturers - Major

  1. How Merck Found Its Way Into Millions Of Medicine ...

    How Merck Found Its Way Into Millions Of Medicine ...

    With over $40 billion in revenue from pharmaceutical sales, there's a good chance ...
  2. How Gilead Sciences Became A Big Name In Biotech

    How Gilead Sciences Became A Big Name In Biotech

    How does a company start with an unfortunate bout of dengue fever and grow to be ...
  3. Want To Make Money In Marijuana? Read This First ...

    Want To Make Money In Marijuana? Read This First ...

    "Investing in cannabis" used to mean buying grow-lights for a hydroponic operation. ...
  4. What Are The Best Bets In Biotech?

    What Are The Best Bets In Biotech?

    The NASDAQ Biotechnology Index is off nearly 20% as its components busy themselves ...
  5. How Some Brands Come Back from Near Death

    How Some Brands Come Back from Near Death

    Some company brands manage to revive themselves, while others die and go to brand ...
  6. It's No Accident That Drugs Are Expensive

    It's No Accident That Drugs Are Expensive

    Branded drugs are expensive in large part because it's expensive and risky to develop ...
  1. Investing In Biotech: Is It Worth The Risk?

    Investing In Biotech: Is It Worth The Risk?

    Investors shunned biotech after a weak start in 2014. Now that a comeback is in the ...
  2. 4 Large-Cap Healthcare Stocks To Watch

    4 Large-Cap Healthcare Stocks To Watch

    Healthcare continues to a be a hot sector. Here are four pharma stocks to keep an ...
  3. Why There's Far More To Pfizer Than Viagra

    Why There's Far More To Pfizer Than Viagra

    Pfizer, Inc. is one of the world's largest and most profitable pharmaceutical companies, ...
  4. Yet Another Failure Has Rigel Pharmaceuticals ...

    Yet Another Failure Has Rigel Pharmaceuticals ...

    Rigel sees yet another clinical failure from its pipeline.
  5. AstraZeneca Goes Back To The M&A Well Yet Again

    AstraZeneca Goes Back To The M&A Well Yet Again

    AstraZeneca's acquisition of Amplimmune could pay big dividends in a decade.
  6. Amgen Sweetens The Bid And Secures Onyx

    Amgen Sweetens The Bid And Secures Onyx

    Amgen finalizes a value-additive deal for Onyx
Trading Center